HER2+ CNS Surveillance

Recruiting now · Not applicable

Conditions studied: Her 2 Positive Breast Cancer, Cancer, CNS

In brief

A multi-centre, randomised study, to determine the feasibility of recruiting men and women with metastatic HER2 positive breast cancer to a study with a baseline MRI scan followed by randomising to surveillance by two further six-monthly MRI scans versus no further surveillance of the brain. Qualitative research (focus groups and/or interviews) and monitoring of approach and consent with SEAR framework will be embedded within the trial to achieve the primary endpoint and explore challenges with study implementation and delivery.

Key facts

Study ID
NCT07748598
Run by
The Clatterbridge Cancer Centre NHS Foundation Trust
People needed
69
Starts
2025-10-03
Expected to finish
2027-12-31
Last updated by the study team
2026-08-05

Who can join

Age: 16 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.